A bioartificial system acts as 'dialysis' for failing livers in pigs

July 08, 2020

A bioartificial system that incorporates enhanced liver cells can act as an analogous form of dialysis for the liver in pigs, effectively carrying out the organ's detoxifying roles and preventing further liver damage in animals with acute liver failure. With further development, the system could provide a new and much needed treatment for patients with acute liver failure, which can have a mortality rate of up to 80%. Acute liver failure can be caused by factors ranging from drug overdoses to liver surgery. The only effective intervention for acute liver failure is liver transplantation, but this approach is often impractical due to shortages of donor organs, the need for immunosuppressive drugs, and the fact that some patients are considered incompatible for transplantation. To address this treatment gap, Wei-Jian Li and colleagues created their air-liquid interactive bioartificial liver (Ali-BAL), a bioreactor-based extracorporeal system that cultures liver progenitor-like cells on scaffolds to provide complete liver function. When connected to the body's vasculature, the Ali-BAL takes in blood through a series of pumps and plasma filters, exposes it to the liver cells in the bioreactor, and returns detoxified blood to the body. The scientists tested their system in a pig model of acute liver failure induced by drug overdose and found that three hours of treatment was enough to detoxify compounds such as ammonia, prevent liver inflammation, and enhance liver regeneration. The treatment was also safe and greatly improved survival, with 5 out of 6 treated pigs surviving versus 1 out of 6 untreated pigs. Li et al. note that further experiments should test their system's effectiveness against other forms of acute liver failure, such as that induced by surgical procedures, before moving to clinical studies in humans.
-end-


American Association for the Advancement of Science

Related Transplantation Articles from Brightsurf:

A revolutionary new treatment alternative to corneal transplantation
A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.

Fewer complications after organ transplantation
A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients.

Elderly patients also benefit from kidney transplantation
So far, kidney transplantation has generally not been offered to elderly patients (>75 years) because of the perioperative risks.

New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.

Fewer medical tests -- timely listing for transplantation
Younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.

Uterus transplantation -- ethically just as problematic as altruistic surrogacy
In 2014, the first child to have been gestated in a donated uterus was born.

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

Transplantation followed by antiviral therapy cured hepatitis C
Twenty patients who received kidneys transplanted from hepatitis C virus (HCV)-infected donors experienced HCV cure, good quality of life, and excellent renal function at one year.

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Older donor lungs should be considered for transplantation
With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published online today in The Annals of Thoracic Surgery.

Read More: Transplantation News and Transplantation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.